Betabar Eye Dops 0.5% 5Ml
Levobunolol is a non-cardioselective beta-adrenoceptor blocking agent, equipotent at both beta-1 and beta-2 receptors
Levobunolol is a non-cardioselective beta-adrenoceptor blocking agent, equipotent at both beta-1 and beta-2 receptors. Levobunolol does not have significant local anaesthetic (membrane-stabilizing) or intrinsic sympathomimetic activity. The primary mechanism of the ocular hypotensive activity of levobunolol hydrochloride is likely to be a decrease in aqueous humour production. There is little effect on pupil size or accommodation.
Purpose
Glaucoma
Ingredients
Levobunolol HCl
Warnings
If you have a history of breathing problems or heart disease your doctor may monitor you more closely as in rare cases death has been reported following taking levobunolol.
Regular eye examination is required during prolonged and repeated use as the preservative benzalkonium chloride can cause damage to your eyes.
Ophthalmic ß-blockers may induce dryness of eyes. Patients with corneal diseases is advised to be treated with caution.
Side Effects
• Eye irritation/eye pain • Irritation/redness of the outermost layer of the eye • Inflammation of the eyelids and outermost layer of the eye dry eye • Decreased blinking, inflammation of the iris and inner eye or surface of the eye, trouble with your vision, itching of the eye/eye lids, eye and/or eyelid swelling/puffiness, eye discharge or tearing, foreign body sensation in the eye .
Storage Instructions
Store this medicine at room temperature, away from direct light and heat.
| Brand | Barrett |
| Status | Active |